Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.690
-0.030 (-1.74%)
At close: Apr 28, 2026, 4:00 PM EDT
1.700
+0.010 (0.59%)
After-hours: Apr 28, 2026, 7:16 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $24.24 million as of April 28, 2026. Its market cap has increased by 10.71% in one year.
Market Cap
24.24M
Enterprise Value
24.68M
1-Year Change
10.71%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $24.24M, a decrease of -72.65%. That is a compound annual growth rate of -23.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 24.24M | 71.43% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 27.57M |
| Longeveron | 27.52M |
| NanoViricides | 27.21M |
| Neuphoria Therapeutics | 27.17M |
| AEON Biopharma | 26.57M |
| NeuroSense Therapeutics | 26.52M |
| ABVC BioPharma | 26.44M |
| Barinthus Biotherapeutics | 26.22M |